Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Research

Exposure to di-2-ethylhexyl phthalate (DEHP) increases the risk of cancer

Authors: Luchen Yang, Xiaoyang Liu, Zhufeng Peng, Zhenghuan Liu, Pan Song, Jing Zhou, Kai Ma, Yunfei Yu, Qiang Dong

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Cancer is a major socioeconomic burden that seriously affects the life and spirit of patients. However, little is known about the role of environmental toxicant exposure in diseases, especially ubiquitous di-(2-ethylhexyl) phthalate (DEHP) which is one of the most widely used plasticizers. Hence, the objective of this study was to assess the potential association between cancer and DEHP. The data were collected using the 2011–2018 National Health and Nutrition Examination Survey (NHANES) data (n = 6147), and multiple logistic regression was conducted to evaluate the association. The concentrations of DEHP were calculated by each metabolite and split into quartiles for analysis. After adjusting for confounding factors, DEHP was significantly associated with an increased risk of cancer prevalence, and the metabolites of DEHP showed similar results (OR > 1.0, p < 0.05). Simultaneously, the association remained when the analyses were stratified by age and sex, and the risk of cancer appeared to be higher in male patients. In addition, further analysis suggested that DEHP exposure obviously increased the risk of female reproductive system cancer, male reproductive system cancer, and other cancers (OR > 1.0, p < 0.05) but not skin and soft tissue cancer. DEHP exposure is associated with the risk of cancer, especially female reproductive system cancer, male reproductive system cancer and other cancers.
Literature
2.
go back to reference Henley SJ, et al. Annual report to the nation on the status of cancer, part I: national cancer statistics. Cancer. 2020;126(10):2225–49.CrossRefPubMed Henley SJ, et al. Annual report to the nation on the status of cancer, part I: national cancer statistics. Cancer. 2020;126(10):2225–49.CrossRefPubMed
4.
go back to reference Islami F, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31–54.CrossRefPubMed Islami F, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31–54.CrossRefPubMed
5.
go back to reference Cumberbatch MGK, et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784–95.CrossRefPubMed Cumberbatch MGK, et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784–95.CrossRefPubMed
7.
go back to reference Eslami Doost Z, Dehghani S, Samaei MR, Arabzadeh M, Baghapour MA, Hashemi H, Oskoei V, Mohammadpour A, De Marcoc A. Dispersion of SO2 emissions in a gas refinery by AERMOD modeling and human health risk: a case study in the Middle East. Int J Environ Health Res. 2023:1–14. Eslami Doost Z, Dehghani S, Samaei MR, Arabzadeh M, Baghapour MA, Hashemi H, Oskoei V, Mohammadpour A, De Marcoc A. Dispersion of SO2 emissions in a gas refinery by AERMOD modeling and human health risk: a case study in the Middle East. Int J Environ Health Res. 2023:1–14.
8.
go back to reference Dehghani S, Abedinzade A, Mohebat V. Ambient air pollution exposure and thyroid cancer incidence in Iran. J Air Pollut Health 2021;6(1). Dehghani S, Abedinzade A, Mohebat V. Ambient air pollution exposure and thyroid cancer incidence in Iran. J Air Pollut Health 2021;6(1).
9.
go back to reference Dehghani S, et al. Exposure to air pollution and risk of ovarian cancer: a review. Rev Environ Health. 2023;38(3):439–50.CrossRefPubMed Dehghani S, et al. Exposure to air pollution and risk of ovarian cancer: a review. Rev Environ Health. 2023;38(3):439–50.CrossRefPubMed
10.
go back to reference ATSDR. Toxicological profile for di(2-ethylhexyl)phthalate. Atlanta: United States Public Health Service; 2022. ATSDR. Toxicological profile for di(2-ethylhexyl)phthalate. Atlanta: United States Public Health Service; 2022.
11.
go back to reference Casals-Casas C, Desvergne B. Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol. 2011;73:135–62.CrossRefPubMed Casals-Casas C, Desvergne B. Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol. 2011;73:135–62.CrossRefPubMed
13.
go back to reference Hines CJ, et al. Estimated daily intake of phthalates in occupationally exposed groups. J Expo Sci Environ Epidemiol. 2011;21(2):133–41.CrossRefPubMed Hines CJ, et al. Estimated daily intake of phthalates in occupationally exposed groups. J Expo Sci Environ Epidemiol. 2011;21(2):133–41.CrossRefPubMed
15.
go back to reference Sharpe RM. Hormones and testis development and the possible adverse effects of environmental chemicals. Toxicol Lett. 2001;120(1–3):221–32.CrossRefPubMed Sharpe RM. Hormones and testis development and the possible adverse effects of environmental chemicals. Toxicol Lett. 2001;120(1–3):221–32.CrossRefPubMed
16.
go back to reference IARC, Working Group on the evaluation of carcinogenic risks to human: some chemicals present in industrial and consumer products, food and drinking water. 9–549. IARC, Working Group on the evaluation of carcinogenic risks to human: some chemicals present in industrial and consumer products, food and drinking water. 9–549.
17.
go back to reference Voss C, et al. Lifelong exposure to di-(2-ethylhexyl)-phthalate induces tumors in liver and testes of Sprague-Dawley rats. Toxicology. 2005;206(3):359–71.CrossRefPubMed Voss C, et al. Lifelong exposure to di-(2-ethylhexyl)-phthalate induces tumors in liver and testes of Sprague-Dawley rats. Toxicology. 2005;206(3):359–71.CrossRefPubMed
18.
go back to reference Zhu M, et al. Phthalates promote prostate cancer cell proliferation through activation of ERK5 and p38. Environ Toxicol Pharmacol. 2018;63:29–33.CrossRefPubMed Zhu M, et al. Phthalates promote prostate cancer cell proliferation through activation of ERK5 and p38. Environ Toxicol Pharmacol. 2018;63:29–33.CrossRefPubMed
19.
go back to reference Yong W, et al. Mono-2-ethyhexyl phthalate advancing the progression of prostate cancer through activating the hedgehog pathway in LNCaP cells. Toxicol In Vitro. 2016;32:86–91.CrossRefPubMed Yong W, et al. Mono-2-ethyhexyl phthalate advancing the progression of prostate cancer through activating the hedgehog pathway in LNCaP cells. Toxicol In Vitro. 2016;32:86–91.CrossRefPubMed
20.
go back to reference Xia B, et al. In utero and lactational exposure of DEHP increases the susceptibility of prostate carcinogenesis in male offspring through PSCA hypomethylation. Toxicol Lett. 2018;292:78–84.CrossRefPubMed Xia B, et al. In utero and lactational exposure of DEHP increases the susceptibility of prostate carcinogenesis in male offspring through PSCA hypomethylation. Toxicol Lett. 2018;292:78–84.CrossRefPubMed
21.
go back to reference Crobeddu B, et al. Di(2-ethylhexyl) phthalate (DEHP) increases proliferation of epithelial breast cancer cells through progesterone receptor dysregulation. Environ Res. 2019;173:165–73.CrossRefPubMed Crobeddu B, et al. Di(2-ethylhexyl) phthalate (DEHP) increases proliferation of epithelial breast cancer cells through progesterone receptor dysregulation. Environ Res. 2019;173:165–73.CrossRefPubMed
22.
go back to reference Zhang X, et al. Co-exposure to BPA and DEHP enhances susceptibility of mammary tumors via up-regulating Esr1/HDAC6 pathway in female rats. Ecotoxicol Environ Saf. 2021;221:112453.CrossRefPubMed Zhang X, et al. Co-exposure to BPA and DEHP enhances susceptibility of mammary tumors via up-regulating Esr1/HDAC6 pathway in female rats. Ecotoxicol Environ Saf. 2021;221:112453.CrossRefPubMed
23.
go back to reference Wang Y, et al. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China. Neurourol Urodyn. 2011;30(8):1448–55.CrossRefPubMed Wang Y, et al. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China. Neurourol Urodyn. 2011;30(8):1448–55.CrossRefPubMed
24.
go back to reference Trnka B, Polan M, Zigmont VA. Exposure to Di-2-ethylhexyl phthalate (DEHP) and infertility in women, NHANES 2013–2016. Reprod Toxicol. 2021;103:46–50.CrossRefPubMed Trnka B, Polan M, Zigmont VA. Exposure to Di-2-ethylhexyl phthalate (DEHP) and infertility in women, NHANES 2013–2016. Reprod Toxicol. 2021;103:46–50.CrossRefPubMed
25.
go back to reference O’Brien KM, Upson K, Buckley JP. Lipid and creatinine adjustment to evaluate health effects of environmental exposures. Curr Environ Health Rep. 2017;4(1):44–50.CrossRefPubMedPubMedCentral O’Brien KM, Upson K, Buckley JP. Lipid and creatinine adjustment to evaluate health effects of environmental exposures. Curr Environ Health Rep. 2017;4(1):44–50.CrossRefPubMedPubMedCentral
26.
go back to reference Hauser R, et al. Urinary phthalate metabolite concentrations and reproductive outcomes among women undergoing in vitro fertilization: results from the EARTH study. Environ Health Perspect. 2016;124(6):831–9.CrossRefPubMed Hauser R, et al. Urinary phthalate metabolite concentrations and reproductive outcomes among women undergoing in vitro fertilization: results from the EARTH study. Environ Health Perspect. 2016;124(6):831–9.CrossRefPubMed
28.
go back to reference Chuang SC, et al. Phthalate exposure and prostate cancer in a population-based nested case-control study. Environ Res. 2020;181:108902.CrossRefPubMed Chuang SC, et al. Phthalate exposure and prostate cancer in a population-based nested case-control study. Environ Res. 2020;181:108902.CrossRefPubMed
30.
go back to reference Miao H, et al. Associations of urinary phthalate metabolites with risk of papillary thyroid cancer. Chemosphere. 2020;241:125093.ADSCrossRefPubMed Miao H, et al. Associations of urinary phthalate metabolites with risk of papillary thyroid cancer. Chemosphere. 2020;241:125093.ADSCrossRefPubMed
31.
go back to reference Chou CY, et al. Urine phthalate metabolites are associated with urothelial cancer in chronic kidney disease patients. Chemosphere. 2021;273:127834.ADSCrossRefPubMed Chou CY, et al. Urine phthalate metabolites are associated with urothelial cancer in chronic kidney disease patients. Chemosphere. 2021;273:127834.ADSCrossRefPubMed
32.
go back to reference Ito Y, et al. Di(2-ethylhexyl)phthalate induces hepatic tumorigenesis through a peroxisome proliferator-activated receptor alpha-independent pathway. J Occup Health. 2007;49(3):172–82.CrossRefPubMed Ito Y, et al. Di(2-ethylhexyl)phthalate induces hepatic tumorigenesis through a peroxisome proliferator-activated receptor alpha-independent pathway. J Occup Health. 2007;49(3):172–82.CrossRefPubMed
33.
go back to reference Chen HP, et al. Phthalate exposure promotes chemotherapeutic drug resistance in colon cancer cells. Oncotarget. 2018;9(17):13167–80.CrossRefPubMed Chen HP, et al. Phthalate exposure promotes chemotherapeutic drug resistance in colon cancer cells. Oncotarget. 2018;9(17):13167–80.CrossRefPubMed
34.
go back to reference Chou CK, et al. The impact of Di(2-ethylhexyl)phthalate on cancer progression. Arch Immunol Ther Exp (Warsz). 2018;66(3):183–97.ADSCrossRefPubMed Chou CK, et al. The impact of Di(2-ethylhexyl)phthalate on cancer progression. Arch Immunol Ther Exp (Warsz). 2018;66(3):183–97.ADSCrossRefPubMed
35.
go back to reference Hsieh TH, et al. DEHP mediates drug resistance by directly targeting AhR in human breast cancer. Biomed Pharmacother. 2022;145:112400.CrossRefPubMed Hsieh TH, et al. DEHP mediates drug resistance by directly targeting AhR in human breast cancer. Biomed Pharmacother. 2022;145:112400.CrossRefPubMed
36.
go back to reference Benjamin S, et al. Phthalates impact human health: epidemiological evidences and plausible mechanism of action. J Hazard Mater. 2017;340:360–83.CrossRefPubMed Benjamin S, et al. Phthalates impact human health: epidemiological evidences and plausible mechanism of action. J Hazard Mater. 2017;340:360–83.CrossRefPubMed
37.
go back to reference David RM. Proposed mode of action for in utero effects of some phthalate esters on the developing male reproductive tract. Toxicol Pathol. 2006;34(3):209–19.CrossRefPubMed David RM. Proposed mode of action for in utero effects of some phthalate esters on the developing male reproductive tract. Toxicol Pathol. 2006;34(3):209–19.CrossRefPubMed
38.
go back to reference Hannon PR, et al. Mono(2-ethylhexyl) phthalate accelerates early folliculogenesis and inhibits steroidogenesis in cultured mouse whole ovaries and antral follicles. Biol Reprod. 2015;92(5):120.CrossRefPubMedPubMedCentral Hannon PR, et al. Mono(2-ethylhexyl) phthalate accelerates early folliculogenesis and inhibits steroidogenesis in cultured mouse whole ovaries and antral follicles. Biol Reprod. 2015;92(5):120.CrossRefPubMedPubMedCentral
41.
go back to reference Sugino M, et al. Safety evaluation of dermal exposure to phthalates: metabolism-dependent percutaneous absorption. Toxicol Appl Pharmacol. 2017;328:10–7.CrossRefPubMed Sugino M, et al. Safety evaluation of dermal exposure to phthalates: metabolism-dependent percutaneous absorption. Toxicol Appl Pharmacol. 2017;328:10–7.CrossRefPubMed
Metadata
Title
Exposure to di-2-ethylhexyl phthalate (DEHP) increases the risk of cancer
Authors
Luchen Yang
Xiaoyang Liu
Zhufeng Peng
Zhenghuan Liu
Pan Song
Jing Zhou
Kai Ma
Yunfei Yu
Qiang Dong
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-17801-w

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue